CHP Seminar - MaHTAS
We are pleased to welcome the Director of The Malaysian Health Technology Assessment Section (MaHTAS), Dr. Izzuna Mudla Mohamed Ghazali, to speak at our upcoming CHP seminar.
MaHTAS was established in August 1995 under the Medical Programme, Ministry of Health (MOH) in keeping with the Ministry’s policy of ensuring that safe, effective and cost-effective technology is being used in the MOH facilities. This is done through the conduct of Health Technology Assessment (HTA), Mini-HTA (Technology Review), Information Brief (rapid assessment) and horizon scanning of emerging health technologies. The scope of activities of this section has also been expanded to develop and implement national Evidence-based Clinical Practice Guidelines (CPG) in 2001.
MaHTAS’ mission is advocating evidence-informed health decision making by:
- Producing transparent, relevant, accessible health technology assessment, clinical practice guidelines and other synthesized research evidence
- Fostering collaboration with local and international stakeholders
- Strengthening health technology assessment capacity in Malaysia
- Empowering consumer
Dr Izzuna Ghazali, along with her colleague, Ku Nurhasni Ku Abd Rahim from the Ministry of Health, Malaysia, will introduce the history of MaHTAS, explain how MaHTAS works and MaHTAS role during COVID-19.They will discuss the types of projects that MaHTAS has undertaken, including dissemination activities, and future plans. MaHTAS is a member of the International Network of Agencies for Health Technology Assessment (INAHTA).